Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...

Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...

The latest data from Johnson and Johnson's Rybrevant and Lazcluze lung cancer combo was better than standard of care Tagrisso ...

Foghorn Therapeutics advances FHD-909 for SMARCA4 tumors, backed by Eli Lilly partnership. Read here to know why we are ...

Positive preliminary data from the phase 1b/2 trial evaluating Olvi-Vec in small cell lung cancer have been announced.

Lung cancer is one of the most challenging diseases, making early diagnosis crucial for effective treatment. Fortunately, ...

Systemic administration of Olvi-Vec in the initial dose escalation cohorts achieved a 71% disease control rate (5/7) with two partial ...

A groundbreaking study has revealed a significant link between the frequency of chest X-ray referrals from GPs and earlier ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

Doctors stage non-small cell lung cancer (NSCLC) according to how far it has progressed. Stages range from occult (or hidden) cancer to stage 4 cancer, in which multiple organs may be affected.

This repository contains a Lung Cancer Detection Model built using Machine Learning techniques. The project aims to assist in the early detection of lung cancer using medical imaging data and patient ...

Lung cancer is a disease in which cancerous cells form in the tissues around and inside the lung. There are various types of this disease. Non-small cell lung cancer (NSCLC) is a disease where cancer ...